Evaluates composite dietary antioxidant index association with chronic kidney disease risk, suggesting implications for dietary interventions.
BACKGROUND: Chronic kidney disease (CKD) poses a significant global health burden, with oxidative stress implicated in its pathogenesis. The composite dietary antioxidant index (CDAI), integrating multiple dietary antioxidants, may offer a novel approach to CKD risk assessment, yet evidence remains limited. OBJECTIVE: This study aimed to evaluate the association between CDAI and CKD risk in a nationally representative U.S. MATERIALS AND METHODS: or UACR ≥ 30 mg/g. Multivariable logistic regression, restricted cubic splines (RCS), and subgroup analyses were employed to assess associations, adjusted for demographics, lifestyle, comorbidities, and laboratory parameters. RESULTS: Participants in the highest CDAI quartile (Q4) had a 27% lower CKD risk (adjusted OR = 0.73, 95% CI: 0.62 - 0.87, p < 0.001) vs. Q1, with a dose-dependent relationship (p-trend < 0.001). RCS revealed nonlinear effects, with steep risk reduction at CDAI < 10 and plateauing at CDAI > 20. Subgroup analyses showed stronger inverse associations in women, older adults (≥ 65 years), and individuals with diabetes or cardiovascular disease (p-interaction < 0.05). Mediation analysis indicated direct effects of CDAI, independent of traditional risk factors. CONCLUSION: Higher CDAI levels were independently associated with reduced CKD risk, particularly in high-risk subgroups. These findings support the potential role of dietary antioxidants in CKD prevention, warranting further prospective validation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: